Attention Retailers! Vote for the products that make a positive impact on your bottom line in WholeFoods Magazine's Natural ...

a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and hematological malignancies, is presenting clinical data from a completed Phase 1 trial ...

Long­time dig­i­tal health com­pa­ny Quan­tum Health has laid off work­ers days af­ter it ap­point­ed a new CEO, End­points News has learned.

Sam­sung Bi­o­log­ics closed 2024 on sev­er­al high notes, reach­ing its high­est an­nu­al rev­enue to date — and just a week ago, se­cur­ing its largest client con­tract … ...

Sen-Jam Pharmaceutical announced that it has received an investment from 5 Horizons Capital to advance a Phase II clinical trial for SJP-001, a novel therapy for inflammation and metabolic health ...

1,2 Historically, when humans were hunter-gatherers with an unpredictable food supply, the regulation of hunger primarily involved maintaining a metabolic equilibrium between caloric intake and ...

The City of Lethbridge has launched Phase 2 of public engagement for its Land Use Bylaw (LUB) Renewal Project. Project Manager Genesis Molesky describes ... The results from the LUB Phase 1 survey are ...

Resources giant Fortescue has committed to the next phase of advancing a novel green ... Fortescue is committing $1.48 million for this stage of the project, giving it a 36% stake in the joint ...

No later than day 16 after the start of the ceasefire, the parties agreed to start negotiating the second phase. On day 22, civilians will be allowed to return north from both al-Rashid Street and ...

LISBON — Columbiana County Commissioner Mike Halleck said the resolution to place the 1% sales tax renewal on the May 6 ballot will be passed next week and will include a line that says renewal.

An 800 megawatt (MW) pumped hydro project proposed for development across five properties and two shires northwest of Biloela in Queensland has appeared in the public portal for the federal ...

The upcoming Phase 1/2 clinical trial, dubbed RESET-MS, will enroll adults, ages 18-60, who have either relapsing or progressive forms of MS. To be eligible, patients with relapsing MS must have ...